Insights obtained by profiling immune response to repeat viral infections could assist vaccine design efforts

March 27, 2013, Agency for Science, Technology and Research (A*STAR), Singapore
Immunology: Bracing for a viral counterattack
Antibodies (green) isolated from patients with a secondary dengue infection can effectively label cultured infected cells, demonstrating their strong affinity for the viral particle. Credit: 2013 A*STAR Singapore Immunology Network

Patients who successfully beat infection with dengue virus remain vulnerable to reinfection by other dengue variants, and these secondary infections tend to be more severe. The antibodies arising from the immune system's first encounter with the virus can play a complicated role in how these secondary infections unfold.

" made during dengue infection can be either protective or disease enhancing," explains Katja Fink of the A*STAR Singapore Network. Fink and her team wanted to determine whether the antibodies produced very early after infection promote defense or vulnerability. To do this, her team isolated plasmablasts—immature precursors of antibody-secreting —from two patients newly diagnosed with secondary infection. After conducting assays to determine the extent to which these cells were targeting the various subtypes of dengue virus, the researchers learned that most patient plasmablasts were specifically generating antiviral antibodies (see image).

The secret of the 's success is its diversity, but when the body finds a threat that resembles something it has previously encountered, it specifically stimulates proliferation of cells that secrete antibodies appropriate to that threat. Fink and co-workers characterized the extent to which antibodies produced by individual plasmablasts from such patients neutralized different dengue variants in a . They found that the antibodies were generally more effective at neutralizing strains from initial infections rather than those involved in secondary infections. This is in keeping with an immunological model called 'antigenic original sin', wherein an initial encounter with a pathogen determines antibody output generated in subsequent encounters.

Importantly, the researchers found that patients with acute secondary infections were also able to successfully mount a new wave of plasmablast-mediated against the secondary strain, manifested by the generation of a collection of antibodies that effectively recognized and neutralized all four viral subtypes. More than a few very potent antibodies dominate the protective effect, according to Fink. "The immune system responds to dengue with a very diverse repertoire," she notes. Based on the timing with which the antibodies appeared, the researchers were also able to determine that they help rather than hinder the body's antiviral effort.

The cross-protective antibodies generated in this acute plasmablast response preferentially recognized a particular viral coat protein as a target, or 'epitope'. If validated in larger scale studies, these results could lead to better antiviral protection. "Knowledge about antibody epitopes on the virus that are naturally targeted by the human immune response could be translated into the design of vaccines," says Fink.

Explore further: Human antibody for dengue virus isolated

More information: Xu, M. et al. Plasmablasts generated during repeated dengue infection are virus glycoprotein–specific and bind to multiple virus serotypes. The Journal of Immunology 189, 5877–5885 (2012). www.jimmunol.org/content/early … nol.1201688.abstract

Related Stories

Human antibody for dengue virus isolated

June 22, 2012
(Phys.org) -- A group of scientists in Singapore and the UK have isolated a human antibody capable of effectively neutralizing the mosquito-borne dengue virus. Dengue fever is currently incurable and infects an estimated ...

Researchers identify Achilles heel of dengue virus, target for future vaccines

April 11, 2012
A team of scientists from the University of North Carolina at Chapel Hill and Vanderbilt University have pinpointed the region on dengue virus that is neutralized in people who overcome infection with the deadly pathogen. ...

Antibodies are not required for immunity against some viruses

March 1, 2012
A new study turns the well established theory that antibodies are required for antiviral immunity upside down and reveals that an unexpected partnership between the specific and non-specific divisions of the immune system ...

Recommended for you

Novel genomic tools provide new insight into human immune system

January 19, 2018
When the body is under attack from pathogens, the immune system marshals a diverse collection of immune cells to work together in a tightly orchestrated process and defend the host against the intruders. For many decades, ...

Genomics reveals key macrophages' involvement in systemic sclerosis

January 18, 2018
A new international study has made an important discovery about the key role of macrophages, a type of immune cell, in systemic sclerosis (SSc), a chronic autoimmune disease which currently has no cure.

First vaccine developed against grass pollen allergy

January 18, 2018
Around 400 million people worldwide suffer in some form or other from a grass pollen allergy (rhinitis), with the usual symptoms of runny nose, cough and severe breathing problems. In collaboration with the Viennese firm ...

Researchers discover key driver of atopic dermatitis

January 17, 2018
Severe eczema, also known as atopic dermatitis, is a chronic inflammatory skin condition that is driven by an allergic reaction. In their latest study, researchers at La Jolla Institute reveal an important player that promotes ...

Who might benefit from immunotherapy? New study suggests possible marker

January 16, 2018
While immunotherapy has made a big impact on cancer treatment, the fact remains that only about a quarter of patients respond to these treatments.

Researchers identify new way to unmask melanoma cells to the immune system

January 16, 2018
system, which enables these deadly skin cancers to grow and spread.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.